# Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium

> **NCT00351299** · PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 53 (actual)

## Conditions studied

- Delirium
- Agitation

## Interventions

- **DRUG:** Dexmedetomidine
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT00351299
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2017-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351299, "Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT00351299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*